Neoadjuvant Combination Sintilimab plus Chemotherapy in Patients with Resectable Stage IIIA Non-Small Cell Lung Cancer.

被引：0
|
作者：
Ma, K. [1 ]
Sun, C. [1 ]
Jia, X. [1 ]
Wang, X. [1 ]
Xu, Y. [1 ]
Guo, Y. [1 ]
Qiu, S. [1 ]
Shao, G. [1 ]
Zhang, P. [1 ]
Liu, Y. [1 ]
Ma, X. [1 ]
机构：
[1] First Hosp Jilin Univ, Changchun, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
non-small cell lung cancer; Immunotherapy; neoaduvant;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P79.09
引用
收藏
页码：S649 / S650
页数：2
相关论文
共 50 条
  • [41] A phase II feasibility study of preoperative chemotherapy with bevacizumab for resectable stage II/IIIA non-squamous non-small cell lung cancer.
    Miyata, Yoshihiro
    Tsutani, Yasuhiro
    Suzuki, Kenji
    Takamochi, Kazuya
    Tanaka, Fumihiro
    Nakayama, Haruhiko
    Yamashita, Yoshinori
    Tsuboi, Masahiro
    Oda, Makoto
    Okada, Morihito
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] Gemcitabine combined with cisplatin as neoadjuvant chemotherapy in stage IB-IIIA non-small cell lung cancer
    Davidov, Mikhail I.
    Polotzky, Boris E.
    Marenich, Aleksander F.
    Orlov, Sergey V.
    Lazarev, Aleksander F.
    Skryabina, Lyudmila S.
    Pavlushkov, Eugeniy V.
    Semenchenya, Vladimir A.
    Brichkova, Olga Y.
    Karaseva, Vera V.
    ANTI-CANCER DRUGS, 2011, 22 (06) : 569 - 575
  • [43] Randomized controlled trial of neoadjuvant chemotherapy with cisplatin and vinorelbine in patients with stage IIIA non-small cell lung cancer in China
    Li, Jian
    Yu, Li-Chao
    Chen, Ping
    Shi, Sheng-Bing
    Dai, Chun-Hua
    Wu, Jian-Rong
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2009, 5 (02) : 87 - 94
  • [44] Chemotherapy in resectable non-small cell lung cancer
    Enriqueta Felip
    Revista de Oncología, 2004, 6 (1): : 52 - 56
  • [45] Neoadjuvant camrelizumab and chemotherapy in patients with resectable stage IIIA squamous non-small-cell lung cancer: Clinical experience of three cases
    Li, Xin
    Xia, Chunqiu
    Liu, Minghui
    Liu, Jinghao
    Dong, Ming
    Zhao, Honglin
    Xu, Song
    Wang, Dan
    Wei, Sen
    Song, Zuoqing
    Chen, Gang
    Liu, Hongyu
    Chen, Jun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [46] Neoadjuvant Camrelizumab Combined with Chemotherapy for Resectable Stage IIIA-IIIB Non-Small Cell Lung Cancer: Single Arm Phase II Study
    Cai, G.
    Wang, K.
    Wang, X.
    Zhao, J.
    Wang, Z.
    Han, X.
    Zhou, H.
    Xie, C.
    Fu, S.
    Hui, J.
    Huang, Y.
    Li, W.
    Teng, F.
    Wang, S.
    Yu, J.
    Song, P.
    Meng, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E10 - E10
  • [47] A phase II study of tislelizumab (TIS) and chemotherapy as neoadjuvant therapy for potentially resectable stage IIIA/IIIB non-small cell lung cancer (NSCLC)
    Wang, Ting
    Huang, Lu Li Lin
    Liu, Jie Wei
    Zhu, Da Xing
    Dong, Jing Si
    Deng, Han Yu
    Zheng, Xi
    Tian, Long
    Jiang, Li Li
    Wang, Wei Ya
    Zhou, Ping
    Su, Ming Gang
    Pu, Dan
    Cai, Xu Yu
    Feng, Ming Yang
    Ou, Xue Jin
    Wang, Yongsheng
    Zhou, Qing Hua
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] Neoadjuvant camrelizumab combined with chemotherapy for resectable stage IIIA-IIIb non-small cell lung cancer: Single arm phase II study
    Cai, Guoxin
    Wang, Kaiyue
    Wang, Xiaohan
    Zhao, Jiarui
    Han, Xiao
    Zhou, Haiyan
    Xie, Chao
    Jia, Hui
    Fu, Shuai
    Huang, Yong
    Li, Wanhu
    Teng, Feifei
    Wang, Suzhen
    Yu, Jinming
    Song, Pingping
    Meng, Xue
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] Neoadjuvant immunotherapy for resectable non-small cell lung cancer
    Xie, Hui
    Shi, Xuejun
    Wang, Guangshun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (06): : 2521 - 2536
  • [50] Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer
    Lochrin, Sarah E.
    Forde, Patrick M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (08) : 415 - 423
12345